| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.07 |